Brief: PhaseBio Reports Q3 2020 Financial Results
12/11/2020 21:24
Nov 12 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO REPORTS RECENT BUSINESS HIGHLIGHTS AND
THIRD-QUARTER
2020 FINANCIAL RESULTS
* PHASEBIO PHARMACEUTICALS - CASH AND CASH EQUIVALENTS AT
SEPTEMBER 30, 2020 WERE $39.4 MILLION, COMPARED TO $74.0 MILLION
AT DECEMBER 31, 2019
* PHASEBIO PHARMACEUTICALS - QTRLY LOSS PER SHARE $0.86
Source text for Eikon: ID:nBw7XTfJXa
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans